What question did this study set out to answer?

This study explores the real-world treatment experiences and dosing patterns of adults using low-sodium oxybate for idiopathic hypersomnia.

May 10, 2026SLEEP

1011 Individualized Dosing with Low-Sodium Oxybate in Idiopathic Hypersomnia: Patient Voices from LYRICAL

View Full Paper

Ask AI

Bookmark

Authors

Longitudinal study illustrates individualized dosing benefits in adults with idiopathic hypersomnia, highlighting shared decision-making.

This study explores the real-world treatment experiences and dosing patterns of adults using low-sodium oxybate for idiopathic hypersomnia.
Longitudinal mixed methods study with 40 participants taking low-sodium oxybate for ≥12 weeks.
Quantitative surveys at enrollment, week 12, and week 24, along with qualitative interviews of a subgroup.
Descriptive analyses evaluated dosing patterns and participant perceptions.
85% reported taking low-sodium oxybate twice-nightly, with 9.0 g as the most common nightly dosage.
32.4% had asymmetric dosing, often adjusted for better sleep outcomes.
Most participants found individualized dosing helpful for their lifestyle and reported high treatment satisfaction.

Drachenberg et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark